Podium Lecture
Moderators: James Naylor, Tom Harte
Contributors: Tony Young, Justin Green, Oli Pearce, Helen Compton
Topic: How to take innovative AI ideas forward.
Questions may be submitted in advance or during the session.
James Naylor is a Senior Marketing Manager for Johnson & Johnson MedTech and works across digital technology and Hips. James has been in Orthopaedics as part of Sales or Marketing for more than 20 years starting as a sales rep and moving through to his current role as a Strategic Marketer for the Global Group. In his current role James is responsible for the management and delivery of digital projects within Hips and owns the future roadmaps for digital technology Globally for Hips. James’ role involves sourcing companies and products that fit the roadmaps and onboarding those companies as valued partners.
Helen joined the NIHR CC in 2016 to lead on stakeholder engagement activity with the charity and MedTech communities and provide leadership and delivery across several high profile strategic and operational projects across NIHR.
Helen engages with SMEs, clinicians and charities to support MedTech innovators access the NIHR and wider life sciences ecosystem.
Helen gained an extensive background working at the science-policy interface in Defra (>9 yrs) across several high-profile government programmes. She commissioned R&D programmatic evidence that supported changes in both UK policy and international cooperation and has experience synergising research activity across government departments for domestic and international reporting. Helen has developed evidence supporting several national government strategies and presented evidence-based findings at all organisational levels and internationally to the OECD.
Whilst at the National Physical Laboratory Helen developed extensive touchpoints across the UK public research infrastructure primarily around health and the sectors that impinge on it. She contributed to a national measurement strategy for the UK on behalf of government and helped government prioritise its chemical and biological metrology research funding to support emerging areas of UK measurement need necessary to support industrial growth.
Helen is interested in health innovation and MedTech and has advisory roles in:
• Board member to CW Innovation, the partnership between Chelsea and Westminster NHS Foundation Trust and the Trust’s hospital charity, CW+
• Trustee Orthopaedic Research UK
